# RevOpsis Therapeutics Corp — Form D

RevOpsis Therapeutics Corp of Springfield, IL, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-27. The offering totals $521K. Industry: Biotechnology.

## Offering

- Filed: 2022-06-27
- Form: D
- Accession: 0001914303-22-000006
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $521K
- Remaining: $521K
- Investors: 4
- Date of first sale: 2022-03-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-450242

## Issuer

- Name: RevOpsis Therapeutics Corp
- CIK: 0001914303
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 4109 Chandlerwood Rd, Springfield, IL, 62711
- Phone: 6462215178

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Ramanath Bhandari | Director | Tampa, FL |
| Jeff Olson | Director | Tampa, FL |
| Ram Palanki | Director | Tampa, FL |
| Ramanath Bhandari | Executive Officer | Tampa, FL |
| Ram Palanki | Executive Officer | Tampa, FL |
| Ramanath Bhandari | Promoter | Tampa, FL |

## More

- [CIK 1914303 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1914303&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001914303-22-000006.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.